R
RAPP
Rapport Therapeutics Inc
34.17
-0.05-0.15%After Hours: 34.17 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE34.84/34.65
TODAY RANGE34.46-36.46
VOL496.20K
MARKET CAP1.73B
52 WEEK RANGE7.73-42.27
AVG VOL (3M)324.01K
% TURNOVER1.04%
TURNOVER--
P/E (TTM)-12.6253
% RANGE5.51%
EPS(TTM)-2.8633
P/E(FORWARD)-10.3286
P/B3.563
BVPS10.15
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.62B
SHARES OUTSTANDING47.79M
NEXT EARNINGS05/06-05/11
FREE FLOAT44.93M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Closing Bell Movers: Markets on edge ahead of US-Iran talks
Reuters·04/02 12:07
Harmony Biosciences names Peter Anastasiou COO in executive reshuffle
Dow Jones·03/11 18:32
Rapport Therapeutics Is Maintained at Buy by BTIG
Dow Jones·03/11 18:32
Rapport Therapeutics Price Target Raised to $53.00/Share From $47.00 by BTIG
Benzinga·03/11 18:22
BTIG Maintains Buy on Rapport Therapeutics, Raises Price Target to $53
Dow Jones·03/11 15:19
Rapport Therapeutics Is Maintained at Overweight by Wells Fargo
Dow Jones·03/11 15:19
Rapport Therapeutics Price Target Raised to $46.00/Share From $43.00 by Wells Fargo
Same Industry
Name/Symbol
Change%
Price